Michael Sweeney
Resverlogix Corp
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Sweeney as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:21 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06590324 · A Study of Apabetalone in Subjects With Long -COVIDResverlogix Corp · recruiting · Post-Acute COVID-19 Syndrome · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:21 UTC. The ranking covers the 200 most relevant of 87 PubMed records, and a shared surname and initials can bring in a namesake. All 87 on PubMed
- 741 citationsRCR 21.2
- Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.N Engl J Med · 2002734 citationsRCR 16.4
- 642 citationsRCR 14.7
- 570 citationsRCR 13.4
- Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.J Am Acad Child Adolesc Psychiatry · 2001412 citationsRCR 13.2
- Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.N Engl J Med · 2007384 citationsRCR 10.5
- 251 citationsRCR 8.4
- Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.Circulation · 2001238 citationsRCR 6.2
- 224 citationsRCR 6.1
- Heart failure during cardiac pacing.Circulation · 2006200 citationsRCR 5.5